Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx rlt

  • Home
  •  
  • asx rlt



  • Most Read
  • Latest Comments
  • Renergen develops COVID vaccine transport solution powered by liquid helium
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Renergen develops COVID vaccine transport solution powered by liquid helium
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Renergen develops COVID vaccine transport solution powered by liquid helium
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Renergen develops COVID vaccine transport solution powered by liquid helium
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Renergen develops COVID vaccine transport solution powered by liquid helium
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Increasing wages puts pressure on Millennium Services with no material contracts wins, reports negative cash flow
    Increasing wages puts pressure on Millennium Services with no material contracts wins, reports negative cash flow
    • News

  • AdAlta secures second Japanese patent for its antibody candidate AD-214
    AdAlta secures second Japanese patent for its antibody candidate AD-214
    • News

  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    RATs - The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

  • New rides and Theme Park upgrades – Ardent Leisure poised for pandemic recovery
    New rides and Theme Park upgrades - Ardent Leisure poised for pandemic recovery
    • News

  • Renergen develops COVID vaccine transport solution powered by liquid helium
    Renergen develops COVID vaccine transport solution powered by liquid helium
    • News

  • Renergen develops COVID vaccine transport solution powered by liquid helium
    • News

    Renergen develops COVID vaccine transport solution powered by liquid helium

    With a COVID-19 vaccine tipped to be rolled out globally in the coming months, natural gas company Renergen (ASX: RLT) has developed a product that can transport vaccines which require ultra cold conditions, without the need for a power source. The Cryo-Vacc aims to assist logistics companies with a cost-effective transport solution for vaccines which

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.